1-2 of 2
Becky Habecker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective, Randomized, Chemoprevention Trial of Celecoxib for High Risk Monoclonal Gammopathy of Undetermined Significance and Asymptomatic Multiple Myeloma

Leonard J. Horwitz, MD, Beth Faiman, CNP, Paul Elson, ScD, Rachid Baz, MD, Mohamad Hussein, MD, John A Lust, MD, PhD, Paulette Mehta, MD, MPH, Frederic J. Reu, MD, Becky Habecker, Janice Reed, RN, Mary Ann Karam, RN, Robert M Dean, MD, Ronald Sobecks, MD, Eric D. Hsi, MD, Varsha Kaushal, MD, Matt Kalaycio, MD
Journal: Blood
Blood (2012) 120 (21): 5045.
https://doi.org/10.1182/blood.V120.21.5045.5045
Published: 2012
Journal Articles

Mature Results of MM011: A Phase I/II Trial of Lenalidomide, Liposomal Doxorubicin, Dexamethasone, and Vincristine, Followed by Lenalidomide Maintenance (DVd-R) for Relapsed or Refractory Multiple Myeloma

Aleksandr Lazaryan, MD, MPH, PhD, Rachid Baz, MD, Mohamad A Hussein, Jr, MD, Paul Elson, ScD, Beth Faiman, CNP, Becky Habecker, Mary Ann Karam, RN, Janice Reed, RN, Kimberly Hamilton, RN, Kellie Bruening, Gordan Srkalovic, MD, PhD, Steven Andresen, DO, Matt Kalaycio, MD, John William Sweetenham, MD, FRCP, Ronald Sobecks, MD, Robert Dean, MD, Robert Knight, MD, Jerome B. Zeldis, MD, PhD, Frederic J. Reu, MD
Journal: Blood
Blood (2010) 116 (21): 1967.
https://doi.org/10.1182/blood.V116.21.1967.1967
Published: 2010